Metformin is associated with reduced COVID-19 severity in patients with prediabetes
Authors:
Open Access
- 15 November 2022
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 194, 110157
Abstract
No abstract availableKeywords
All Related Versions
This publication has 64 references indexed in Scilit:
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- MissForest—non-parametric missing value imputation for mixed-type dataBioinformatics, 2011
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyThe Lancet, 2009
- Insulin Resistance in PCOSEndocrine, 2006
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Generalized Collinearity DiagnosticsJournal of the American Statistical Association, 1992
- OndansetronDrugs, 1991
- Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndromeDiabetes, 1989
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987